Table 6.
Virus | Condition | Experiment 1 log TCID50/mL |
Experiment 2 log TCID50/mL |
Experiment 3 log TCID50/mL |
Average TCID50/mL |
TiterReduction |
---|---|---|---|---|---|---|
AdV-5 | Stock | 7.2 | 7.2 | 7.2 | 1.58 × 107 | |
H2O+ | 4.2 | 5.2 | 4.2 | 1.58 × 104 | ||
CCM+ | 4.2 | 4.2 | 4.2 | 1.58 × 104 | ||
FA 5′ | 1.2 | 1.2 | 1.2 | <1.58 × 101 | 6.0 log10 | |
ECHO-11 | Stock | 11.2 | 11.2 | 11.2 | 1.58 × 1011 | |
H2O+ | 11.2 | 11.2 | 11.2 | 1.58 × 1011 | ||
CCM+ | 11.2 | 10.2 | 10.2 | 6.32 × 1010 | ||
FA 5′ | 2.2 | 2.7 ** | 1.2 | 2.25 × 102 | 9.2 log10 ** | |
HIV-1 | Stock | 5.2 | 5.2 | 5.2 | 1.58 × 105 | |
H2O+ | nd | 2.2 | 2.2 | 1.58 × 102 | ||
CCM+ | nd | 2.2 | 4.2 | 7.98 × 103 | ||
FA 5′ | nd | 1.2 | 1.2 | <1.58 × 101 | 4.0 log10 | |
SARS-CoV-2 | Stock | 5.8 | 5.8 | - | 2.8 × 106 | |
H2O+ | 4.9 | 4.9 | - | 8.1 × 104 | ||
CCM+ | 5.4 | 4.9 | - | 1.8 × 105 | ||
FA 5′ | 0.9 | 0.9 | - | 8.1 × 100 | 4.9 log10 |